Oh W K, Manola J, Renshaw A A, Brodkin D, Loughlin K R, Richie J P, Shapiro C L, Kantoff P W
Lank Center for Genitourinary Oncology, Department of Adult Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts 02115, USA.
Urology. 2000 Jan;55(1):31-5. doi: 10.1016/s0090-4295(99)00408-2.
To correlate the clinical outcomes of 148 patients with clear cell renal carcinoma treated at a single institution with a variety of other factors.
Cases were derived from a consecutive series of nephrectomy specimens obtained from 1980 to 1994. A retrospective review of clinical records was performed, with tobacco use, alcohol use, recurrence, and survival noted.
The median age of the patients was 62 years. The median follow-up was 4.4 years. Of 148 patients, 82% had localized disease (MO), and 18% had suspected metastases (M1) at the time of nephrectomy. Of 121 patients without metastases at diagnosis, T classification was assessed for 117: 48 (41%) had T1 disease, 18 (15%) T2, 46 (39%) T3, and 5 (4%) T4. The Fuhrman grade was 1 or 2 in 51% of patients and 3 or 4 in 45%. Both clinical stage and grade were significantly associated with overall survival (P <0.0001 and P = 0.0028, respectively) and recurrence-free survival (P = 0.0002 and P = 0.0011, respectively). Smoking and alcohol use history was determined in 70% and 63% of patients, respectively. In patients with Stage M0, smokers had a significantly worse overall survival rate compared with nonsmokers (P = 0.039). Also, in patients with Stage M0, a trend toward a worse recurrence-free survival rate was noted in alcohol users compared with those who never used alcohol regularly (P = 0.06).
The prognosis of clear cell renal carcinoma depends on the pathologic stage at diagnosis and the Fuhrman grade. Smoking is a known risk factor for developing renal cancer and may be associated with increased mortality from clear cell carcinoma in patients with Stage M0. Also, regular alcohol use may decrease the recurrence-free survival rate.
将在单一机构接受治疗的148例透明细胞肾细胞癌患者的临床结局与多种其他因素进行关联分析。
病例来源于1980年至1994年连续收集的肾切除标本系列。对临床记录进行回顾性分析,记录吸烟、饮酒、复发及生存情况。
患者的中位年龄为62岁。中位随访时间为4.4年。148例患者中,82%在肾切除时为局限性疾病(M0),18%怀疑有转移(M1)。在诊断时无转移的121例患者中,对117例进行了T分期评估:48例(41%)为T1期疾病,18例(15%)为T2期,46例(39%)为T3期,5例(4%)为T4期。51%的患者Fuhrman分级为1或2级,45%为3或4级。临床分期和分级均与总生存期(分别为P<0.0001和P = 0.0028)及无复发生存期(分别为P = 0.0002和P = 0.0011)显著相关。分别有70%和63%的患者记录了吸烟和饮酒史。在M0期患者中,吸烟者的总生存率明显低于不吸烟者(P = 0.039)。此外,在M0期患者中,与从不经常饮酒者相比,饮酒者的无复发生存率有变差的趋势(P = 0.06)。
透明细胞肾细胞癌的预后取决于诊断时的病理分期和Fuhrman分级。吸烟是已知的肾癌发病危险因素,可能与M0期患者透明细胞癌死亡率增加有关。此外,经常饮酒可能会降低无复发生存率。